Učitavanje...
Adherence and Out-of-Pocket Cost Among Medicare Beneficiaries Prescribed Oral Targeted Therapies for Advanced Prostate Cancer
BACKGROUND: Abiraterone and enzalutamide are high-cost oral therapies increasingly used to treat patients with advanced prostate cancer, carrying the potential for significant financial consequences to patients. We investigated coping and material measures of financial hardship of these therapies am...
Spremljeno u:
| Izdano u: | Cancer |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959094/ https://ncbi.nlm.nih.gov/pubmed/32926427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33176 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|